Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
The most important clinical decision with Platelet-Rich Plasma for Foot and Ankle: What PRP Can (and Can’t) Do isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.

Platelet-rich plasma (PRP) injections have become one of the most talked-about treatments in foot and ankle medicine — with good reason, and with significant caveats. PRP harnesses concentrated growth factors from your own blood to accelerate tissue healing, but outcomes vary dramatically by condition, preparation method, and injection technique. This guide covers the evidence, the appropriate indications, and what realistic expectations look like.
What Is PRP and How Does It Work?
Platelet-rich plasma is produced by drawing a patient’s blood, centrifuging it to separate and concentrate platelets, and injecting the resulting platelet-concentrated serum into the target tissue. Platelets contain alpha granules packed with growth factors — including PDGF, TGF-β, VEGF, EGF, and IGF-1 — that regulate tissue repair, collagen synthesis, angiogenesis (new blood vessel formation), and cell proliferation. When concentrated and delivered directly to injured tissue, these growth factors are intended to accelerate and enhance the natural healing response. The concentration of platelets in therapeutic PRP preparations typically ranges from 2× to 9× baseline blood platelet concentration depending on the centrifuge protocol used.
PRP Evidence by Foot and Ankle Condition
| Condition | Evidence Level | Expected Benefit | vs. Cortisone | Clinical Recommendation |
|---|---|---|---|---|
| Chronic plantar fasciitis (6+ months) | Level I–II (multiple RCTs) | Significant pain reduction at 3–12 months; superior to cortisone long-term | Cortisone faster (weeks); PRP more durable (months to years) | Strong indication — especially for patients who have failed cortisone |
| Achilles tendinopathy (chronic) | Level I–II | Moderate pain and function improvement at 6–12 months; better than exercise alone | Comparable to cortisone short-term; PRP better at 12 months (no fascia rupture risk) | Good indication for mid-portion chronic tendinopathy |
| Acute Achilles tendon tear (non-surgical) | Level III | Possible acceleration of healing; limited evidence | Cortisone contraindicated in tendon tears | Adjunct to conservative management; not standard of care |
| Lateral ankle ligament repair (post-surgical) | Level III | Possible faster return to sport | N/A | Emerging — not yet standard of care |
| Osteochondral lesion of talus (OLT) | Level II–III | Modest symptom improvement as adjunct; not definitive for structural lesions | N/A | Adjunct to surgical treatment; not definitive standalone |
| Peroneal tendinopathy | Level III (case series) | Limited published data; clinical experience suggests benefit similar to Achilles | PRP likely safer long-term | Reasonable option after failed conservative care |
| Acute plantar fascia tear | Level IV (expert opinion) | Theoretical — limited evidence | N/A | Not standard; individualized decision |
| Morton’s neuroma | Level III | Some evidence for symptom reduction; alcohol injection has stronger evidence | Inferior to alcohol for neuroma | Secondary option; alcohol/steroids preferred |
PRP Preparation Variables That Affect Outcomes
Not all PRP is the same — preparation variables produce dramatically different products, which explains much of the inconsistency in published outcomes. Leukocyte-rich PRP (L-PRP) contains white blood cells in addition to platelets and may produce more inflammation; some evidence suggests it is better for tendon pathology. Leukocyte-poor PRP (LP-PRP) has fewer WBCs and less pro-inflammatory cytokines; some evidence favors it for joint injection. Platelet concentration matters — ultra-high concentrations above 5× baseline may paradoxically inhibit healing through oversaturation of growth factor receptors. Activation (with thrombin or calcium chloride before injection) is debated. At Balance Foot & Ankle, we use systems with validated centrifuge protocols and platelet concentration verification.
What to Expect: PRP Treatment Timeline
| Timeframe | What Typically Happens | Activity Level |
|---|---|---|
| Day 0 (injection day) | Blood draw (30–60 mL), centrifuge processing (15–20 min), ultrasound-guided injection; moderate discomfort expected | Rest; ice; no NSAIDs for 2 weeks post-injection |
| Days 1–5 | Post-injection flare common (increased soreness from inflammatory healing cascade) | Reduced activity; comfortable footwear; acetaminophen for pain (no NSAIDs) |
| Weeks 1–4 | Initial healing phase; growth factor activity peaks; gradual reduction in baseline pain | Return to light daily activity; avoid high-impact sport |
| Months 2–3 | Collagen remodeling phase; significant clinical improvement in responding patients | Progressive return to activity; physical therapy initiated |
| Months 3–6 | Peak clinical benefit; most patients see maximum improvement | Full return to activity if pain resolved |
| Months 6–12+ | Durability assessment; repeat injection considered if partial but insufficient response | Monitor; consider 2nd injection if 50–80% but not full improvement |
Important Practical Considerations
Stop NSAIDs (ibuprofen, naproxen, aspirin) at least 1 week before PRP — they inhibit platelet function and reduce growth factor release. The injection should be performed under ultrasound guidance for most foot and ankle applications — accuracy matters for outcomes. PRP is not covered by most insurance plans and is typically a cash-pay procedure ranging from $400–$900 per injection. Patients on blood thinners should discuss their medications with the provider; certain anticoagulants may need temporary adjustment. Patients with active infection, platelet disorders, or certain cancers are not candidates.
Balance Foot & Ankle provides ultrasound-guided PRP injections for chronic plantar fasciitis, Achilles tendinopathy, and other appropriate conditions at our Howell and Bloomfield Hills offices. Call (810) 206-1402 to discuss whether PRP is right for your situation.
PubMed: Platelet-Rich Plasma for Foot Conditions
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
For a complete clinical overview: Ankle Pain Conditions Guide — location-by-location ankle pain diagnosis and treatment
Doctor Answer
What is platelet-rich plasma (PRP) therapy for foot and ankle conditions?
PRP therapy concentrates growth factors from the patient’s own blood to accelerate healing in tendons, ligaments, and joints. The blood is drawn, centrifuged to isolate the platelet-rich fraction, and injected under ultrasound guidance into the affected structure. I use PRP for chronic plantar fasciitis, Achilles tendinopathy, and osteochondral lesions that haven’t responded adequately to conventional treatment. Clinical evidence is strongest for plantar fasciitis and Achilles tendinopathy. It is minimally invasive with low complication risk, though results vary and insurance coverage is limited.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.